Pentobarbital: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Pentobarbital. Educational only — not medical advice.

Labeled uses

Parenteral: Sedatives. Hypnotics, for the short-term treatment of insomnia, since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks (See “Clinical Pharmacology ” section.) Preanesthetics. Anticonvulsant, in anesthetic doses, in the emergency control of certain acute convulsive episodes, e.g., those associated with status epilepticus, cholera, eclampsia, meningitis, tetanus, and toxic reactions to strychnine or local anesthetics.

Source: FDA labeling via NIH DailyMed (set 0a202fdc…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.